A study to evaluate whether increasing regulatory T cells by tocilizumab correlates with clinical response in patients with rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 30 Jul 2015 New trial record